Albatha Healthcare Partners With Milab to Advance Regional Diagnostics
Albatha Healthcare strengthens its Middle East presence, leveraging Milab Scientific’s expertise to improve diagnostics and patient outcomes regionally.
Topics
News
- Deloitte Launches Middle East CoE to Drive Agentic AI Adoption
- Albatha Healthcare Partners With Milab to Advance Regional Diagnostics
- NVIDIA’s DGX Spark Puts Petascale AI Power on Every Developer’s Desk
- Cisco and G42 Deepen Partnership to Build Secure AI Infrastructure in the UAE
- How This Saudi Startup Is Building a Global Network of AI Partnerships
- This AI Alliance is Set to Drive Bahrain’s $1 Billion Biotech Leap
[Image source: Chetan Jha/MITSMR Middle East]
As healthcare organizations across the Middle East accelerate efforts to localize innovation and strengthen self-sufficiency in life sciences, strategic consolidation is emerging as a key driver of growth. Against this backdrop, UAE-based Albatha Healthcare Group has made a decisive move to enhance its laboratory and diagnostics capabilities through the acquisition of Milab Scientific, a trusted leader in medical and laboratory solutions, with over four decades of regional expertise.
Milab’s portfolio spans molecular biology and genomics, proteomics and haematology, clinical and veterinary diagnostics, immunohistochemistry, as well as a comprehensive range of laboratory and hospital equipment and consumables.
“This acquisition reflects our commitment to advancing healthcare in the UAE and the region,” said Dr. Hesham Abdalla, Managing Director at Albatha Healthcare. “With Milab, we are not only strengthening our capabilities in diagnostics and laboratory sciences but also enabling innovation that can improve patient outcomes and support the next generation of scientific solutions.”
The acquisition aligns with Albatha Healthcare’s broader growth and innovation strategy aimed at deepening its operational footprint across the healthcare value chain. Anis Dadani, Director of Finance at Albatha Healthcare, noted: “This strategic investment is a calculated move aligned with our long-term growth strategy. With Albatha Healthcare’s operational scale and market reach, we are well-positioned to integrate Milab’s capabilities and expand our portfolio in advanced diagnostics, molecular biology, and laboratory solutions, creating sustainable value for our stakeholders and the broader healthcare sector.”
Joshua Marchon, Business Unit Head at Milab Scientific, reflected on the milestone: “For over four decades, Milab has been driven by quality, service, and innovation. Joining Albatha Healthcare allows us to extend that legacy and bring advanced scientific solutions to more healthcare providers and institutions across the region.”
Through this acquisition, Albatha Healthcare aims to leverage Milab’s technical expertise and its own integrated network to accelerate innovation in diagnostics, broaden access to advanced laboratory solutions, and empower healthcare providers to deliver faster, more precise, and more effective care across the Middle East.
